Biotechnology Value Fund L P

13F Holdings History for CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Symbol: CTMX on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Ownership: 5.77M shares
Security Ownership: 3.5%

BVF PARTNERS L P/IL ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

2025-07-09 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.77M shares of CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX). This represents 3.5% percent ownership of the company. In their previous filing dated 2025-07-09, BIOTECHNOLOGY VALUE FUND L P had reported owning 11.5M shares, indicating a decrease of -50% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BVF PARTNERS L P/IL	3.5%	-47.1%	$14.4M	5.77M	-5,769,231	-50%	$2.50	13G/A	7/3/2025	9 Jul 2025 19:55:34
BVF PARTNERS L P/IL	6.8%		$28.8M	11.5M			$2.50	13G/A	6/30/2025	9 Jul 2025 19:53:01